A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity.

Four siblings presented with congenital diarrhea and various endocrinopathies. Exome sequencing and homozygosity mapping identified five regions， comprising 337 protein-coding genes that were shared by three affected siblings. Exome sequencing identified a novel homozygous N309K mutation in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene， encoding the neuroendocrine convertase 1 precursor (PC1/3) which was recently reported as a cause of Congenital Diarrhea Disorder (CDD). The PCSK1 mutation affected the oxyanion hole transition state-stabilizing amino acid within the active site， which is critical for appropriate proprotein maturation and enzyme activity. Unexpectedly， the N309K mutant protein exhibited normal， though slowed， prodomain removal and was secreted from both HEK293 and Neuro2A cells. However， the secreted enzyme showed no catalytic activity， and was not processed into the 66 kDa form. We conclude that the N309K enzyme is able to cleave its own propeptide but is catalytically inert against in trans substrates， and that this variant accounts for the enteric and systemic endocrinopathies seen in this large consanguineous kindred.